MannKind Corporation (MNKD) - Financial and Strategic SWOT Analysis Review

Summary

MannKind Corporation (MannKind) is a development stage bio-pharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes and cancer. The company’s product pipeline comprises drug candidates at various stages of development.

MannKind Corporation Key Recent Developments

Feb 11, 2013: MannKind Reports Q4 2012 Results
Nov 01, 2012: MannKind Reports Q3 2012 Results
Aug 09, 2012: MannKind Reports Q2 2012 Results
May 09, 2012: MannKind Reports Q1 2012 Results
Feb 22, 2012: MannKind Reports Q4 2011 ResultsGDPH44250FSA

This comprehensive SWOT profile of MannKind Corporation provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. SHOW LESS READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
MannKind Corporation - Key Facts
MannKind Corporation - Key Employees
MannKind Corporation - Key Employee Biographies
MannKind Corporation - Major Products and Services
MannKind Corporation - Pharmaceutical Pipeline Products Data
MannKind Corporation, Pipeline Products by Therapy Area
MannKind Corporation, Pipeline Products by Development Phase
MannKind Corporation - Medical Equipment Pipeline Products Data
MannKind Corporation Pipeline Products by Equipment Type
MannKind Corporation Pipeline Products by Development Stage
MannKind Corporation - History
MannKind Corporation - Company Statement
MannKind Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
MannKind Corporation - Business Description
MannKind Corporation - Corporate Strategy
MannKind Corporation - SWOT Analysis
SWOT Analysis - Overview
MannKind Corporation - Strengths
Strength - First-In-Class Molecule - Afrezza
Strength - Proprietary Technologies
Strength - Focused Research and Development
MannKind Corporation - Weaknesses
Weakness - Legal Proceedings
Weakness - Delay in Approval of Afrezza
MannKind Corporation - Opportunities
Opportunity - Diabetes Market Potential
Opportunity - Market Potential: Oncology
Opportunity - Agreements and Partnerships
MannKind Corporation - Threats
Threat - Uncertain R&D Outcomes
Threat - Government Regulations
Threat - Competitive Landscape
MannKind Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
MannKind Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013
MannKind Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013
MannKind Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
MannKind Corporation, Recent Developments
Feb 11, 2013: MannKind Reports Q4 2012 Results
Nov 01, 2012: MannKind Reports Q3 2012 Results
Aug 09, 2012: MannKind Reports Q2 2012 Results
May 09, 2012: MannKind Reports Q1 2012 Results
Feb 22, 2012: MannKind Reports Q4 2011 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
MannKind Corporation, Key Facts
MannKind Corporation, Key Employees
MannKind Corporation, Key Employee Biographies
MannKind Corporation, Major Products and Services
MannKind Corporation, Number of Pipeline Products by Therapy Area
MannKind Corporation, Number of Pipeline Products by Development Stage
MannKind Corporation, Pipeline Products By Therapy Area and Development Phase
MannKind Corporation Number of Pipeline Products by Equipment Type
MannKind Corporation Pipeline Products by Equipment Type
MannKind Corporation Number of Pipeline Products by Development Stage
MannKind Corporation Pipeline Products by Development Stage
MannKind Corporation, History
MannKind Corporation, Other Locations
MannKind Corporation, Key Competitors
MannKind Corporation, Ratios based on current share price
MannKind Corporation, Annual Ratios
MannKind Corporation, Interim Ratios
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
MannKind Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013
MannKind Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013
MannKind Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
MannKind Corporation, Pipeline Products by Therapy Area
MannKind Corporation, Pipeline Products by Development Phase
MannKind Corporation Pipeline Products by Equipment Type
MannKind Corporation Pipeline Products by Development Stage
MannKind Corporation, Performance Chart (2007 - 2011)
MannKind Corporation, Ratio Charts
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
MannKind Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
MannKind Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013
MannKind Corporation, Medical Equipment, Deals by Type, 2007 to YTD 2013

Pfizer Inc.
Eli Lilly and Company
Emisphere Technologies, Inc.
GlaxoSmithKline plc
Novo Nordisk A/S